Hello!
I’m Dr. Raktim Chattopadhyay
Founder & CEO, Esperer Group
Executive Board Member , India Health Dialogue (IHD) under the Indian Chamber of Business & Commerce
A Visionary in Cancer Research and Ethical Healthcare , Entrepreneur and Author
About Dr. Raktim Chattopadhyay
Dr. Raktim Chattopadhyay is a distinguished healthcare professional, scientist, and entrepreneur whose life’s mission is to serve cancer patients with unwavering empathy and care. He is the Founder & CEO of Esperer Group and also serves as the Executive Board Member of India Health Dialogue (IHD) under the Indian Chamber of Business & Commerce. With a PhD in Cancer Biology and a career spanning over two decades, he has emerged as a beacon of hope for countless individuals battling cancer.
Dr. Chattopadhyay is renowned for his groundbreaking research on the gut microbiota and its relationship with cancer, known as the DiNI Axis, which earned him a prestigious global patent. His work has not only advanced scientific understanding but also paved the way for innovative, science-based approaches to cancer treatment.
A charismatic and spontaneous speaker, Dr. Chattopadhyay is celebrated as a “people’s leader” in the healthcare industry. His entrepreneurial ventures reflect his commitment to ethical and sustainable healthcare solutions, with a particular focus on building a robust, science-driven system for his home country, India.
Throughout his illustrious career, Dr. Chattopadhyay has received numerous prestigious awards for his contributions to cancer research and healthcare. His ability to balance scientific rigor with compassion has made him a trusted name among patients and professionals alike.
Driven by a profound sense of responsibility, Dr. Raktim Chattopadhyay envisions dedicating his last breath to the well-being of cancer sufferers, solidifying his legacy as a tireless advocate for hope, healing, and humanity.
Expertise
Transforming Healthcare Through Science, Innovation, and Personalised Nutrition
Medical Nutrition & Nutraceuticals
Bridging science and health to combat malnutrition and cancer-related challenges.
Cancer Research
Innovating customised nutritional solutions that complement cancer treatment and recovery.
Healthcare Leadership
Overseeing multidisciplinary teams in biotech and pharmaceutical industries.
AI-Driven Healthcare Solutions
Spearheaded the development of an AI-based platform addressing cancer-related malnutrition, offering personalized nutritional assessments and advanced decisionmaking tools.
Nutritional Technology Integration
Integrated med-tech innovations into cancer care, leveraging digital tools to assess and address malnutrition in oncology patients.
Data-Driven Nutritional Strategies
Advocates for the use of advanced data analytics and biomedical attributes to improve patient outcomes through precision nutrition.
Nutrigenomics in Cancer Care
Incorporates nutrigenomic insights into med-tech solutions, facilitating tailored dietary interventions based on genetic and biochemical profiles.
Interdisciplinary Expertise
Combines expertise in molecular biology, biotechnology, and digital health to create holistic solutions for managing non-communicable diseases, including cancer.
Collaborative Healthcare Innovation
Works at the intersection of healthcare and technology, collaborating with clinicians, researchers, and industry experts to enhance patient-centric care through med-tech advancements.
Innovations
Developer of the globally recognized DINI AXIS hypothesis in nutraceutical science.
Awards
Recipient of multiple accolades for contributions to healthcare innovation and entrepreneurship.
Memberships
Served as member of the Task Force, Nutraceutical Council, to the Principal Scientific Advisor’s Office, Government of India.
My Mission
"My mission is to create a world where nutrition is a cornerstone of healthcare, empowering individuals to overcome health challenges with science-backed solutions. I aim to bridge the gap between cutting-edge research and real-world impact, especially in the fight against cancer and malnutrition."
